Yüklüyor......
Belimumab Concentrations in Maternal Serum and Breast Milk During Breastfeeding and the Safety Assessment of the Infant: A Case Study
Background: Belimumab is a recombinant human immunoglobulin G1 lambda monoclonal antibody that binds soluble B lymphocyte stimulator protein with high affinity and inhibits its biological activity. Belimumab is not recommended for breastfeeding women due to insufficient data about its excretion into...
Kaydedildi:
| Yayımlandı: | Breastfeed Med |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Mary Ann Liebert, Inc., publishers
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7374635/ https://ncbi.nlm.nih.gov/pubmed/32326740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/bfm.2020.0068 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|